Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Inolex Investment Corporation has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners and 2 distinct art units, indicating separate examination contexts within the portfolio.
RAMACHANDRAN, UMAMAHESWARI is the busiest examiner, with 1 pending matter. The even distribution supports coordinated scientific and claim strategies, paired with matter-specific responses to the separate examiner and art-unit assignments.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMACHANDRAN, UMAMAHESWARI | 1 | 54.9% | +53.7% |
| KASSA, TIGABU | 1 | 36.6% | +27.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18910700 | Preservatives for Cosmetic, Toiletry and Pharmaceutical Compositions | RAMACHANDRAN, UMAMAHESWARI | — |
| 18661878 | POTASSIUM HYDROGEN SALTS OF ALKYLHYDROXAMATES AND COMPOSITIONS COMPRISING THE SAME | KASSA, TIGABU | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18910700 | Preservatives for Cosmetic, Toiletry and Pharmaceutical Compositions | RAMACHANDRAN, UMAMAHESWARI | 1627 | §112Other | Non-Final OA | — | Pending | Oct 09, 2024 |
| 18661878 | POTASSIUM HYDROGEN SALTS OF ALKYLHYDROXAMATES AND COMPOSITIONS COMPRISING THE SAME | KASSA, TIGABU | 1619 | §103DP | Non-Final OA | — | Pending | May 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInolex Investment Corporation has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Umamaheswari Ramachandran has the most, with 1 of Inolex Investment Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.